Medium due to technology 中因科技

  • Home

  • Gene therapy

    • Drug development

    • Industrialization of pharmaceuticals

    • Quality assurance system

    • Clinical trial

  • News

  • About us

    • Company

    • History

    • Honor

    • Publications

  • CHIGENOVO LAB

中文 /EN

400-6006223

Confirm
NEWS CENTER

NEWS CENTER

09

2024-07

In vitro diagnostic reagents

2024-07-09

09

2024-07

Research Services

2024-07-09

04

2024-07

National High-tech Enterprises

2024-07-04

National High-tech Enterprises

04

2024-07

Zhongguancun high-tech enterprise

2024-07-04

Zhongguancun high-tech enterprise

04

2024-07

Zhongguancun golden seed enterprise

2024-07-04

Zhongguancun golden seed enterprise

04

2024-07

Zhongguancun frontier technology enterprise

2024-07-04

Zhongguancun frontier technology enterprise

04

2024-07

Intellectual property pilot unit

2024-07-04

Intellectual property pilot unit

04

2024-07

Changping district science and technology research and development organization

2024-07-04

Changping district science and technology research and development organization

01

2024-07

Clinical trial sample testing

2024-07-01

01

2024-07

R&D pipeline

2024-07-01

R&D pipeline
< 12345 >
Medium cause

CHIGENOVO Co., Ltd. is an ophthalmic gene therapy company, a national high-tech enterprise focusing on genetic diagnosis of genetic eye diseases and the development of gene therapy drugs. It is committed to providing "one-stop" services for patients with genetic eye diseases.

HUATAO GROUP

Contact us


Telephone:400-6006223   010-82071936
Website:en.chinagene.cc
Address: Floor 4, Area D, Building 1, No.27 Life Garden Road, Zhongguancun Life Science Park, Changping District, Beijing

WeChat subscription account


Medium cause

Powered by www.300.cn | SEO

Business License